-
-
-
-
-
-
-
Vera Therapeutics names Nancy Boman as chief regulatory officer
-
-
-
-
-
-
-
Wolfe Research: 'VERA's continued weakness is creating a favorable setup into the July 7th PDUFA'
-
-
-
-
-
-
-
BofA Securities Reiterates Buy Rating on Vera Therapeutics (VERA): Vertex data "appears to pose no real threat"
-
-
-
-
-
-
-
Vera Therapeutics (VERA) PT Raised to $73 at TD Cowen
-
-
-
-
-
-
-
Buy this biotech stock ahead of underdog commercial launch
-
-
-
-
-
-
-
Raymond James on Vera Therapeutics (VERA): 'we don’t think this is a referendum on the overall efficacy of these drugs in IgAN'
-
-
-
-
-
-
-
Increasing unusual call option volume: CLBR NVTS CERA UMAC TRVI CENX ETHA BOX ONDS RELY IBRX
-
460,581 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

